1-2 of 2
Pavel Simara
Close
Save search
Sort by
Journal Articles

Apoptosis in Chronic Myeloid Leukemia Cells Transiently Treated with Imatinib or Dasatinib Is Caused by Residual BCR-ABL Kinase Inhibition

Free
Pavel Simara, PhD., Stanislav Stejskal, MSc., Irena Koutna, PhD., David Potesil, MSc., Lenka Tesarova, PhD., Michaela Potesilova, MSc., Zbynek Zdrahal, Dr., Jiri Mayer, M.D., PhD., Prof.
Journal: Blood
Blood (2012) 120 (21): 1668.
https://doi.org/10.1182/blood.V120.21.1668.1668
Published: 2012
Journal Articles

Dasatinib Promotes BIM Dependent Apoptosis Via MEK/ERK without Need for Permanent BCR-ABL Inhibition

Free
Pavel Simara, MSc, Stanislav Stejskal, MSc, Peterkova Martina, MSc, Irena Koutna, Ph.D., Zdenek Racil, MD, Jiri Mayer, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 4472.
https://doi.org/10.1182/blood.V116.21.4472.4472
Published: 2010